These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28821955)

  • 1. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.
    Xu X; Li N; Zhao R; Zhu L; Shao J; Zhang J
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2447-2453. PubMed ID: 28821955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA.
    Izumchenko E; Chang X; Brait M; Fertig E; Kagohara LT; Bedi A; Marchionni L; Agrawal N; Ravi R; Jones S; Hoque MO; Westra WH; Sidransky D
    Nat Commun; 2015 Sep; 6():8258. PubMed ID: 26374070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.
    Selamat SA; Galler JS; Joshi AD; Fyfe MN; Campan M; Siegmund KD; Kerr KM; Laird-Offringa IA
    PLoS One; 2011; 6(6):e21443. PubMed ID: 21731750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.
    Sakamoto H; Shimizu J; Horio Y; Ueda R; Takahashi T; Mitsudomi T; Yatabe Y
    J Pathol; 2007 Jul; 212(3):287-94. PubMed ID: 17534846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation profile during multistage progression of pulmonary adenocarcinomas.
    Chung JH; Lee HJ; Kim BH; Cho NY; Kang GH
    Virchows Arch; 2011 Aug; 459(2):201-11. PubMed ID: 21494759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
    Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
    Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
    Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
    Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.
    Hu X; Fujimoto J; Ying L; Fukuoka J; Ashizawa K; Sun W; Reuben A; Chow CW; McGranahan N; Chen R; Hu J; Godoy MC; Tabata K; Kuroda K; Shi L; Li J; Behrens C; Parra ER; Little LD; Gumbs C; Mao X; Song X; Tippen S; Thornton RL; Kadara H; Scheet P; Roarty E; Ostrin EJ; Wang X; Carter BW; Antonoff MB; Zhang J; Vaporciyan AA; Pass H; Swisher SG; Heymach JV; Lee JJ; Wistuba II; Hong WK; Futreal PA; Su D; Zhang J
    Nat Commun; 2019 Jul; 10(1):2978. PubMed ID: 31278276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
    Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.
    Sivakumar S; Lucas FAS; McDowell TL; Lang W; Xu L; Fujimoto J; Zhang J; Futreal PA; Fukuoka J; Yatabe Y; Dubinett SM; Spira AE; Fowler J; Hawk ET; Wistuba II; Scheet P; Kadara H
    Cancer Res; 2017 Nov; 77(22):6119-6130. PubMed ID: 28951454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
    Awaya H; Takeshima Y; Furonaka O; Kohno N; Inai K
    J Clin Pathol; 2005 Oct; 58(10):1076-80. PubMed ID: 16189154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thin-section computed tomography-histopathologic comparisons of pulmonary focal interstitial fibrosis, atypical adenomatous hyperplasia, adenocarcinoma in situ, and minimally invasive adenocarcinoma with pure ground-glass opacity.
    Si MJ; Tao XF; Du GY; Cai LL; Han HX; Liang XZ; Zhao JM
    Eur J Radiol; 2016 Oct; 85(10):1708-1715. PubMed ID: 27666606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging features of TSCT predict the classification of pulmonary preinvasive lesion, minimally and invasive adenocarcinoma presented as ground glass nodules.
    Liu Y; Sun H; Zhou F; Su C; Gao G; Ren S; Zhou C; Zhang Z; Shi J
    Lung Cancer; 2017 Jun; 108():192-197. PubMed ID: 28625634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive changes in the protein expression profile of alveolar septa in early-stage lung adenocarcinoma.
    Kimura T; Akazawa T; Mizote Y; Nakamura H; Sakaue M; Maniwa T; Shintani Y; Honma K; Tahara H; Okami J
    Int J Clin Oncol; 2024 Jun; 29(6):771-779. PubMed ID: 38600426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
    Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
    J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target.
    Kimura K; Matsumoto S; Harada T; Morii E; Nagatomo I; Shintani Y; Kikuchi A
    Cancer Sci; 2020 Mar; 111(3):951-961. PubMed ID: 31925985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression.
    Inamura K
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Profiling of Non-Small Cell Lung Cancer in Moroccan Patients by Targeted Next-Generation Sequencing.
    El Zaitouni S; Laraqui A; Ghaouti M; Benzekri A; Kettani F; Boustany Y; Benmokhtar S; Lamrani Alaoui H; El Annaz H; Abi R; Tagajdid MR; El Kochri S; El Mchichi B; Bouaiti EA; Lahlou IA; El Hassani RA; Ennibi K
    Technol Cancer Res Treat; 2024; 23():15330338241288907. PubMed ID: 39363851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent Prognosis of Patients With Invasive Lung Adenocarcinomas During Surgery Misdiagnosed as Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, or Minimally Invasive Adenocarcinoma by Frozen Section.
    Zhang Y; Deng C; Fu F; Ma Z; Wen Z; Ma X; Wang S; Li Y; Chen H
    Chest; 2021 Mar; 159(3):1265-1272. PubMed ID: 33197404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.